recent phase ii trials of cisplatin indicated a significant single agent activity on gastric cancer and non-hodgkin lymphoma and , therefore , clinical usefulness in combination with other agents has been under investigation .
C0008838
cisplatin
C0024305
non-hodgkin lymphoma